PHASE II PHARM STUDY--FLAVOPIRADOL (NSC 649890) IN COLORECTAL CANCER

II 期药物研究——FLAVOPIRADOL (NSC 649890) 治疗结直肠癌

• 批准号: 6264069
• 负责人: Ross C Donehower
• 金额: $ 0.23万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6264069
• 关键词: clinical research; colorectal neoplasms; drug screening /evaluation; human subject; human therapy evaluation; neoplasm /cancer chemotherapy

You are being asked to join a research study of an experimental treatment for colorectal cancer. You have cancer that cannot be cured or controlled with surgery or radiation treatment. Drug treatment many be helpful in reducing symptoms from this disease. In this study we want to see if the experimental drug flavopiridol can help patients with colorectal cancer

您被邀请参加一项针对结直肠癌的实验性治疗研究。 您患有无法通过手术或放射治疗治愈或控制的癌症。 药物治疗可能有助于减轻这种疾病的症状. 在这项研究中，我们想看看实验性药物flavopiridol是否可以帮助结直肠癌患者